AdvisorShares Psychedelics ETF PSIL
19.23 USD -0.16 (-0.85%)
At closeNov 13, 2026, 7:30 PM EST
19.23 0.00 0.00%
After hours · Nov 13, 7:30 PM ET
18.88 Day range 19.79
15.64 52-week range 26.80
- YTD
- +12.00%
- 1 year
- +8.16%
News
benzinga.com NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.
benzinga.com COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy Compass Pathways' stock surges after late-stage depression trial success.
benzinga.com Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
benzinga.com 'Texas Governor Signs Bill To Create Ibogaine Research Consortium, Aiming To Develop FDA-Approved Psychedelic Drug' - Marijuana Moment https://www.marijuanamoment.net/texas-governor-signs-bill-to-create-ibogaine-research-consortium-aiming-to-develop-fda-approved-psychedelic-drug/
benzinga.com "Colorado Governor Says Bill He Signed Allowing Psychedelic Convictions To Be Pardoned Marks A Step 'Towards A Fairer Future'" - Marijuana Moment https://www.marijuanamoment.net/colorado-governor-says-bill-he-signed-allowing-psychedelic-convictions-to-be-pardoned-marks-a-step-towards-a-fairer-future/
benzinga.com 'Doctor Seeking To Reschedule Psilocybin To Treat Dying Patients Demands DEA Update After Agency Agreed To Initiate Federal Review' - Marijuana Moment https://www.marijuanamoment.net/doctor-seeking-to-res